Risk Minimization of Antibody–Drug Conjugates in Oncology: A Review
Fabio Lievano, Linda Scarazzini, Jerzy E. Tyczynski, Charles Schubert, Cheryl Renz
Topics & Concepts
MedicineTolerabilityDrugIntensive care medicineClinical trialPharmacologyOncologyMedical physicsAdverse effectInternal medicineHER2/EGFR in Cancer ResearchCancer Treatment and PharmacologyCAR-T cell therapy research